All News

Number of patients treated/procedures performed per year – 1,200 radical prostatectomies performed in 2008.

Clinical Centers of Excellence - Prostate Cancer: Mayo Clinic by the numbers

Johns Hopkins' James Buchanan Brady Urological Institute in fiscal 2008 received $9 million in grants from the National Cancer Institute.

Clinical Centers of Excellence - Prostate Cancer: Johns Hopkins University by the numbers

Clinical Centers of Excellence – Prostate Cancer: Cleveland Clinic – Selection criteria

Clinical Centers of Excellence – Prostate Cancer: Cleveland Clinic by the numbers

The National Association For Continence (NAFC) announced Roger Dmochowski, MD, as the latest recipient of its Rodney Appell Continence Care Champion award.

UCLA has launched a patient-centered institute dedicated to developing therapies for the treatment of kidney, bladder, testicular, and prostate cancers.

Novasys Medical, Inc. (Newark, CA) recently announced that Noridian Administrative Services, LLC, a regional Medicare carrier, is now covering the non-surgical Renessa treatment for women with stress urinary incontinence.

New data analyses from a phase III clinical trial suggest favorable results using an investigational form of immunotherapy in men with prostate cancer.

Researchers have reported positive preliminary results from a phase II study of AT-101 in combination with docetaxel (Taxotere) and prednisone in men with docetaxel-refractory, castrate-resistant prostate cancer.

The discontinuation of routine PSA screening in certain elderly men may not increase the rates of undetected lethal disease and could avoid potentially unnecessary treatments and reduce diagnostic costs, according to a new study.

360 Network

This article provides an overview of the 2007 EAU-AUA Nephrolithiasis Guidelines.

This revised surgical approach uses a single suturing process that improves outcomes.

The nation is in the midst of a recession, and confidence in the economy continues to deteriorate. Many experts consider the health care industry to be more resilient than most, but how well a practice does depends on the decisions you make.

Today, targeted therapy is the first choice for most patients with metastatic renal cell carcinoma, but some patients can still be reasonably treated with immunotherapy, according to study results presented at the European Society for Medical Oncology 33rd Congress.

In patients with metastatic renal cell carcinoma treated with the novel compound pazopanib, tumor response could be correlated with several prognostic factors, investigators reported at the European Society for Medical Oncology 33rd Congress here.

Recent reports have suggested that single-incision laparoscopic surgery (SILS) is technically feasible.

First-line treatment with a novel agent known as sagopilone yields a high response rate and substantial decline in PSA in men with androgen-independent prostate cancer, according to findings presented at the European Society for Medical Oncology 33rd Congress.

A majority of surgeons feel that laparoscopic training has had a positive effect on their current open surgical skills, according to research presented at the 2008 World Congress of Endourology & SWL.

AUA lobbyists face huge challenges on Capitol Hill involving four issues important to urologists.

While urology program directors are impressed with this year's group of residency interviewees, some flaws and some generational differences are evident.

Effective communication and documentation lessen the chances for claims and markedly improve the likelihood for successful defense of a claim.

The Worker, Retiree, and Employer Recovery Act of 2008, which was signed into law at the end of last year, has a dramatic positive impact on those who are subject to minimum distributions from their individual retirement accounts.

Most practicing physicians will have to deal with the medical malpractice industry at least once in their career despite their best efforts to employ standards of care and reasonable risk management.

Medicare will pay for services provided in the postoperative period if the services fall under these rules: "Treatment for postoperative complications that requires a return trip to the operating room (OR)."

There is a significant correlation between Comet assay results and the likelihood of pregnancy using ART.

The likelihood of successful sperm extraction may be higher at later stage sperm maturation arrest (MA), according to a study conducted by researchers at Baylor College of Medicine, Houston that was presented at the American Society for Reproductive Medicine annual meeting.

Injecting an immunofluorescent dye into the testes may eventually help clinicians locate individual sperm and improve the yield from microdissection testicular sperm extraction (mTESE), researchers from the University of Iowa, Iowa City, reported at the American Society for Reproductive Medicine annual meeting.